Unilever PLC (LSE:ULVR), Nestlé India Limited (BSE:500790) and Coca-Cola India Private Limited have begun due diligence on GlaxoSmithKline Consumer Healthcare Limited (BSE:500676) which includes Horlicks and Boost, and is estimated to be worth about $4 billion, three people aware of the developments said. Spokespersons at HUL, Nestle and Coca-Cola said they wouldnot comment on speculation'.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4,292 GBX | -0.45% | -0.60% | +12.89% |
May. 23 | The market is good to go until Nvidia’s next quarterly results | |
May. 23 | JPMorgan Upgrades Unilever to Overweight from Underweight, Boosts PT | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.89% | 137B | |
+12.93% | 391B | |
+17.59% | 76.9B | |
-10.75% | 67.16B | |
-13.76% | 45.23B | |
-9.71% | 37.22B | |
+7.77% | 35.44B | |
+10.40% | 18.13B | |
+15.52% | 16.21B | |
+0.76% | 11.92B |
- Stock Market
- Equities
- ULVR Stock
- News Unilever PLC
- Unilever, Nestle And Coca-Cola Reportedly Begin Due Diligence On Glaxosmithkline Consumer Healthcare